Stay updated with breaking news from Gaurav Narula. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAR T-cell therapy involves modifying a patient’s T-cells—white blood cells that are integral to the immune system. The lab-modified cells are then infused in the patient to multiply and fight cancerous cells. The therapy costs $400,000 in the US and tenth of that in India. But, does it work?
A revolutionary, cutting-edge cure is promising hope for millions of cancer patients in India. CAR-T therapy, developed by Dr Gaurav Narula and his team of doctors, is now commercially available in India in just under Rs 50 lakh, as compared to its Rs 4 crore price tag in the US.
Science News: Since January, various hospitals across India have started advertising the availability of NexCAR19 to treat certain blood cancers. Research papers on
From curiosity to groundbreaking cure: How a team in India developed a game-changing cancer therapy. You won't believe the results!
ImmunoACT intends to make the NexCAR19 (Actaly cabtagene autoleucel) therapy available to its partner hospitals as soon as possible